Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
13
Published: June 3, 2022
The
host
epigenetic
landscape
rapidly
changes
during
SARS-CoV-2
infection,
and
evidence
suggest
that
severe
COVID-19
is
associated
with
durable
scars
to
the
epigenome.
Specifically,
aberrant
DNA
methylation
in
immune
cells
alterations
clocks
blood
relate
COVID-19.
However,
a
longitudinal
assessment
of
states
from
healthy
individuals
prior
following
test-confirmed
non-hospitalized
has
not
been
performed.
Moreover,
impact
mRNA
vaccines
upon
epigenome
remains
understudied.
Here,
we
first
examined
21
participants
diagnosis
at
median
time
frame
8.35
weeks;
756
CpGs
were
identified
as
differentially
methylated
an
FDR
adjusted
p
-value
<
0.05.
These
enriched
gene
body,
northern
southern
shelf
regions
genes
involved
metabolic
pathways.
Integrative
analysis
revealed
overlap
among
transcriptional
infection
datasets.
Principal
component-based
clock
estimates
PhenoAge
GrimAge
significantly
increased
people
over
50
by
average
2.1
0.84
years.
In
contrast,
PCPhenoAge
decreased
fewer
than
2.06
This
observed
divergence
was
related
age
cell-type
compositional
CD4
+
T
cells,
B
granulocytes,
plasmablasts,
exhausted
naïve
cells.
Complementary
analyses
36
Pfizer
Moderna
mRNA-based
vaccination
reduced
principal
Horvath
3.91
years
for
those
who
received
Moderna.
reduction
chronological
plasmablasts
pre-
post-vaccination.
findings
potential
utility
biomarker
vaccine
responses.
Future
research
will
need
unravel
significance
durability
short-term
exposure
vaccination.
Science Immunology,
Journal Year:
2023,
Volume and Issue:
8(82)
Published: Feb. 23, 2023
The
relationship
between
diabetes
and
coronavirus
disease
2019
(COVID-19)
is
bidirectional:
Although
individuals
with
high
blood
glucose
(hyperglycemia)
are
predisposed
to
severe
COVID-19,
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection
can
also
cause
hyperglycemia
exacerbate
underlying
metabolic
syndrome.
Therefore,
interventions
capable
of
breaking
the
network
SARS-CoV-2
infection,
hyperglycemia,
hyperinflammation,
all
factors
that
drive
COVID-19
pathophysiology,
urgently
needed.
Here,
we
show
genetic
ablation
or
pharmacological
inhibition
mitochondrial
pyruvate
carrier
(MPC)
attenuates
after
influenza
pneumonia.
MPC
using
a
second-generation
insulin
sensitizer,
MSDC-0602K
(MSDC),
dampened
pulmonary
inflammation
promoted
lung
recovery
while
concurrently
reducing
levels
hyperlipidemia
viral
pneumonia
in
obese
mice.
Mechanistically,
enhanced
fitness
destabilized
hypoxia-inducible
factor-1α,
leading
virus-induced
inflammatory
responses
both
murine
human
macrophages.
We
further
showed
MSDC
nirmatrelvir
(the
antiviral
component
Paxlovid)
provide
protection
against
host
development
suppressed
cellular
autopsies,
demonstrating
its
translational
potential
for
treating
COVID-19.
Collectively,
uncover
pathway
simultaneously
modulates
inflammation,
tissue
recovery,
health,
presenting
synergistic
therapeutic
strategy
treat
particularly
patients
disease.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(3)
Published: June 1, 2023
Type
2
diabetes
mellitus
(T2DM)
represents
one
of
the
fastest
growing
epidemic
metabolic
disorders
worldwide
and
is
a
strong
contributor
for
broad
range
comorbidities,
including
vascular,
visual,
neurological,
kidney,
liver
diseases.
Moreover,
recent
data
suggest
mutual
interplay
between
T2DM
Corona
Virus
Disease
2019
(COVID-19).
characterized
by
insulin
resistance
(IR)
pancreatic
β
cell
dysfunction.
Pioneering
discoveries
throughout
past
few
decades
have
established
notable
links
signaling
pathways
pathogenesis
therapy.
Importantly,
number
substantially
control
advancement
core
pathological
changes
in
T2DM,
IR
dysfunction,
as
well
additional
pathogenic
disturbances.
Accordingly,
an
improved
understanding
these
sheds
light
on
tractable
targets
strategies
developing
repurposing
critical
therapies
to
treat
its
complications.
In
this
review,
we
provide
brief
overview
history
pathways,
offer
systematic
update
role
mechanism
key
underlying
onset,
development,
progression
T2DM.
content,
also
summarize
current
therapeutic
drugs/agents
associated
with
treatment
complications,
discuss
some
implications
directions
future
field.
Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
13
Published: June 3, 2022
The
host
epigenetic
landscape
rapidly
changes
during
SARS-CoV-2
infection,
and
evidence
suggest
that
severe
COVID-19
is
associated
with
durable
scars
to
the
epigenome.
Specifically,
aberrant
DNA
methylation
in
immune
cells
alterations
clocks
blood
relate
COVID-19.
However,
a
longitudinal
assessment
of
states
from
healthy
individuals
prior
following
test-confirmed
non-hospitalized
has
not
been
performed.
Moreover,
impact
mRNA
vaccines
upon
epigenome
remains
understudied.
Here,
we
first
examined
21
participants
diagnosis
at
median
time
frame
8.35
weeks;
756
CpGs
were
identified
as
differentially
methylated
an
FDR
adjusted
p
-value
<
0.05.
These
enriched
gene
body,
northern
southern
shelf
regions
genes
involved
metabolic
pathways.
Integrative
analysis
revealed
overlap
among
transcriptional
infection
datasets.
Principal
component-based
clock
estimates
PhenoAge
GrimAge
significantly
increased
people
over
50
by
average
2.1
0.84
years.
In
contrast,
PCPhenoAge
decreased
fewer
than
2.06
This
observed
divergence
was
related
age
cell-type
compositional
CD4
+
T
cells,
B
granulocytes,
plasmablasts,
exhausted
naïve
cells.
Complementary
analyses
36
Pfizer
Moderna
mRNA-based
vaccination
reduced
principal
Horvath
3.91
years
for
those
who
received
Moderna.
reduction
chronological
plasmablasts
pre-
post-vaccination.
findings
potential
utility
biomarker
vaccine
responses.
Future
research
will
need
unravel
significance
durability
short-term
exposure
vaccination.